Key result
PCI for LMCA compression in pulmonary arterial hypertension yields sustained symptom relief with ~30% 36-month events.
Why the study?
Left main coronary artery compression is increasingly recognized as a cause of angina in patients with pulmonary arterial hypertension, but its prevalence and management are not well defined.
Does CTCA screening and subsequent PCI improve symptoms and outcomes in patients with PAH and angina?
Observational (n=765)
No
Does CTCA screening and subsequent PCI improve symptoms and outcomes in patients with PAH and angina?
In patients with PAH and angina, LMCA compression is highly prevalent, and CTCA screening followed by PCI for significant stenosis provides sustained symptom relief with favorable long-term outcomes.
BACKGROUND: Left main coronary artery (LMCA) compression is increasingly recognized as a cause of angina in pulmonary arterial hypertension (PAH). OBJECTIVES: This study aimed to evaluate the prevalence of LMCA extrinsic compression from a dilated pulmonary artery (PA) in patients with PAH and angina or angina-like symptoms, determine the usefulness of screening with computed tomography coronary angiography (CTCA), and assess the safety and efficacy of percutaneous coronary interventions (PCIs). METHODS: All patients with PAH and angina or angina-like symptoms attending the center between May 1, 2008, and December 31, 2013, underwent CTCA. Patients with confirmed LMCA stenosis on selective coronary angiography had PCI. RESULTS: Of 765 patients with PAH, 121 had angina or angina-like symptoms. Ninety-four patients had abnormal CTCA based on the relationship between the PA and the LMCA and underwent selective coronary angiography. LMCA stenosis ≥50% was detected in 48 of the 94 patients. Forty-five patients underwent PCI with stenting, of whom 41 had sustained angina symptom relief. The 3 other patients had surgical PA reduction plasty. Nine months after PCI, 5 patients had LMCA restenosis and PCI was successfully repeated. The best predictor of LMCA stenosis ≥50% was a PA diameter ≥40 mm. Rates for death or double-lung transplant and the composite rates for death, double-lung transplant, or restenosis at 36 months were 5% and 30%, respectively. CONCLUSIONS: The prevalence of LMCA compression in patients with PAH and angina is high. These results suggest that CTCA is indicated in patients with PAH and angina or angina-like symptoms. PCI was well tolerated, improved symptoms, and resulted in favorable long-term outcomes.
No takes yet. Share an insight, caveat, or question.
Galiè et al. (2017) conducted an observational in Pulmonary arterial hypertension and angina (n=765). Percutaneous coronary intervention (PCI) was evaluated on Composite of death, double-lung transplant, or restenosis at 36 months. In patients with pulmonary arterial hypertension and angina, PCI for left main coronary artery compression provided sustained symptom relief with a 36-month composite event rate of 30%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: